Latest News | Pivotal CRO

Sarah Cannon development innovations collaborates with Pivotal on immuno-oncology trials

April 25, 2018

New collaboration aims to further accelerate the delivery of novel treatments for multiple difficult-to-treat cancers in Europe

Sarah Cannon Development Innovations announced today a new strategic collaboration with Pivotal...

Pivotal has participated in the 36th annual JP Morgan healthcare conference

February 2, 2018

The annual conference was held in San Francisco (California)

Pivotal, represented by members of our Senior Management, has participated in the 36th Annual JP Morgan HealthCare Conference held in...

Pivotals hit in the European Society for Medical Oncology congress

February 2, 2018

ESMO took place in Madrid from the 08th until the 12th of September

On Tuesday, September 12th, the European Society for Medical Oncology Congress (ESMO) ended in Madrid as...

Pivotal participates in the 2017 European Society for Medical Oncology (ESMO) congress in Madrid, Spain

August 2, 2017

Pivotal and ESMO working on different levels to improve prevention, diagnosis, treatment, and palliative care of cancer patients through clinical research

Pivotal, the Madrid-based, European-wide Clinical Research Organization (CRO),...

Pivotal´s success in the European Hematology Association congress (EHA) with a high impact on the media

July 4, 2017

Important online media coverage

On Sunday, June 25th, the 22nd European Hematology Association Congress (EHA) came to a close. The conference was held at the IFEMA Trade Fair Institution...

Pivotal participates in the European Hematology Association (EHA) congress

May 22, 2017

The EHA congress will be held for the first time in Madrid

Pivotal, the Madrid-based European-wide Clinical Research Organisation (CRO), is participating with a booth at the forthcoming <a...

News